TrialFind
Saved trials
Back to results
Completed
Phase 4
Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment
NCT06664138
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Dankook University Hospital
Cheonan, South Korea
View on ClinicalTrials.gov
Official details
Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment — TrialFind